Chris Lancelot: Controlling prescribing costs without interfering

Last week, I discussed what I see as a clumsy attempt by NHS Bedfordshire to reduce the costs of statin prescribing by using Annex 8 to surcharge practices which don't hit its arbitrary 74 per cent simvastatin target.

The GP Record, by Fran Orford
The GP Record, by Fran Orford

In case you thought this was merely a localised, provincial difficulty, think again. NHS bodies across the UK are likely to try to adopt surcharging in order to deliver the prescribing economies needed in the coming cash-strapped era. This approach risks affecting all of us, wherever we practise.

As it happens, I am fully in favour of prescribing targets - but not implemented like this. Nevertheless, this incident has highlighted the urgent need to develop ways of cutting prescribing costs, using sensitive and sensible methods rather than blunderbuss ones.

But how can NHS organisations keep control of prescribing costs without interfering with clinical freedom? It is quite feasible. The first rule is: never impose a target which, to allow for exceptions, aims on the low side. Instead, impose a high target - perhaps even 98 per cent - but allow extended exception reporting. Reasons include: intolerance to the preferred lower-cost medication; non-availability of that medication; or where different medication has been recommended by a consultant unit.

There should also be an exception 'on clinical grounds', which would need to be spelled out in full in the patient's notes.

This should include 'patient unsuitability' and 'patient insistence'.

Crucially, GPs should also be able to except patients because, in their opinion, either the suggested low-cost medication has deleterious side-effects, or the higher-cost alternative has significant benefits.

Clearly this exception is open to abuse and should be monitored by inspection teams: the requirement should not be to provide a cast-iron argument in an area which is obviously a matter of medical debate, but instead to produce clear evidence that the clinician has thought carefully before prescribing.

A high target with extensive exception reporting would force clinicians both to prescribe thoughtfully, and to toe the line over using cheaper drugs wherever possible: equally, it would accommodate patients with a clear medical need and, crucially, protect GPs' clinical freedom.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Follow Us:

Just published

Boris Johnson, Sajid Javid and NHS chief executive Amanda Pritchard at Downing Street press conference

GPs offered £15 per jab as government sets 31 January COVID-19 booster deadline

COVID-19 vaccine payments to GP practices will rise nearly a fifth to £15 per jab...

Houses of parliament

Evidence for mandatory NHS staff COVID-19 jabs 'not good enough', says Lords committee

Evidence to support government plans to require all NHS staff in patient-facing roles...

Dr Farah Jameel

Practices 'need substantial support' to step up Omicron response, warns BMA GP chair

General practice is already facing unsustainable pressure and will need 'substantial...

JCVI COVID-19 immunisation chair Professor Wei Shen Lim

JCVI backs immediate expansion of COVID-19 vaccination to combat Omicron variant

The COVID-19 booster campaign should expand immediately to people aged 18-39 and...

Close up of hand holding sample tube with 'Omicron' handwritten on side

Government urged to 'free up' GP practices and expand steps to control Omicron

GPs have called for immediate action such as suspension of QOF to allow practices...

(Photo: Mike Kemp/Getty Images)

Coronavirus: Key guidance GPs need to know about COVID-19

GPonline provides an overview of the key guidance relating to coronavirus, including...